• LAST PRICE
    7.8800
  • TODAY'S CHANGE (%)
    Trending Up0.1800 (2.3377%)
  • Bid / Lots
    7.8500/ 4
  • Ask / Lots
    7.8900/ 3
  • Open / Previous Close
    7.7000 / 7.7000
  • Day Range
    Low 7.2900
    High 7.9000
  • 52 Week Range
    Low 5.9900
    High 13.5000
  • Volume
    91,463
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 7.7
TimeVolumeAURA
09:32 ET17327.86
09:38 ET1007.68
09:41 ET23117.655
09:43 ET5997.52
09:48 ET4007.45
09:50 ET2007.46
09:52 ET1007.49
09:54 ET2007.495
09:57 ET1007.41
10:01 ET4007.32
10:03 ET1007.38
10:06 ET1007.3875
10:08 ET2007.38
10:10 ET3007.3801
10:12 ET1007.38
10:14 ET24457.485
10:24 ET10447.565
10:30 ET72007.63
10:32 ET68857.67
10:35 ET31597.7
10:39 ET14357.64
10:44 ET2007.6
10:48 ET45177.715
10:51 ET11007.71
10:53 ET2007.7
10:55 ET5007.71
10:57 ET1007.71
11:00 ET54717.725
11:02 ET2007.7
11:04 ET4007.7
11:06 ET22027.65
11:08 ET29587.71
11:09 ET6087.73
11:11 ET2507.745
11:13 ET1007.745
11:15 ET1297.7627
11:22 ET3007.77
11:24 ET3007.745
11:26 ET1007.78
11:27 ET1007.765
11:29 ET1007.75
11:33 ET1007.745
11:38 ET2297.75
11:40 ET13007.81
11:45 ET3007.81
12:00 ET7417.77
12:02 ET2007.805
12:05 ET2007.805
12:12 ET3007.77
12:14 ET1007.75
12:18 ET1007.76
12:20 ET1007.76
12:21 ET1007.77
12:27 ET3007.76
12:30 ET1007.75
12:32 ET2007.775
12:36 ET3207.765
12:38 ET2007.74
12:41 ET2247.71
12:45 ET2007.74
12:50 ET1007.71
12:52 ET1007.74
12:54 ET1007.715
12:56 ET2007.74
12:57 ET1007.715
12:59 ET1007.735
01:01 ET1007.745
01:03 ET40587.85
01:12 ET2547.82
01:14 ET11007.85
01:26 ET2007.75
01:30 ET2007.76
01:32 ET1007.75
01:33 ET28257.85
01:42 ET2007.81
01:46 ET1007.83
01:50 ET1007.825
01:53 ET2007.82
01:55 ET1007.827
01:57 ET1007.81
02:00 ET2007.81
02:02 ET2007.8
02:04 ET7007.84
02:09 ET6007.88
02:11 ET1007.83
02:15 ET1007.83
02:20 ET2007.82
02:22 ET3007.82
02:24 ET2007.8
02:27 ET3007.81
02:29 ET9007.85
02:31 ET1007.82
02:40 ET9007.83
02:44 ET1007.83
02:45 ET1007.82
02:49 ET2007.81
02:54 ET9007.83
02:56 ET13007.89
02:58 ET2527.8932
03:00 ET10007.88
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAURA
Aura Biosciences Inc
378.0M
-4.0x
---
United StatesEPIX
ESSA Pharma Inc
378.7M
-14.5x
---
United StatesTHRD
Third Harmonic Bio Inc
382.2M
-9.1x
---
United StatesCRBP
Corbus Pharmaceuticals Holdings Inc
373.2M
-3.8x
---
United StatesFBLG
Fibrobiologics Inc
383.5M
-12.0x
---
United StatesKOD
Kodiak Sciences Inc
390.9M
-1.1x
---
As of 2024-03-28

Company Information

Aura Biosciences, Inc. is a clinical-stage biotechnology company focused on developing virus-like drug conjugates (VDCs), a novel class of therapies for the treatment of multiple oncology indications. The Company’s lead VDC candidate, AU-011 (belzupacap sarotalocan), consists of a virus-like particle conjugated with an anti-cancer agent. AU-011 consists of human papillomavirus (HPV)-derived VLP conjugated to hundreds of infrared laser-activated molecules. AU-011 selectively targets and destroys cancer cells and activates the immune system with the potential to create long-lasting anti-tumor immunity. AU-011 is in development for ocular cancers and has initiated activities for the global Phase III trial evaluating first-line treatment of early-stage choroidal melanoma. It seeks to develop AU-011 across its ocular oncology franchise. In addition, the Company is developing AU-011 across multiple cancers, including in patients with non-muscle invasive bladder cancer.

Contact Information

Headquarters
80 Guest StreetBOSTON, MA, United States 01235
Phone
617-500-8864
Fax
302-655-5049

Executives

Independent Chairman of the Board
David Johnson
President, Chief Executive Officer, Director
Elisabet de los Pinos
Chief Financial Officer
Julie Feder
Chief Medical Officer and President of Research & Development
J. Jill Hopkins
Independent Director
Giovanni Mariggi

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$378.0M
Revenue (TTM)
$0.00
Shares Outstanding
49.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.95
Book Value
$5.18
P/E Ratio
-4.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.